Acetyl-l-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats

Giulio Taglialatela, D. Navarra, R. Cruciani, M. T. Ramacci, G. S. Alemà, L. Angelucci

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The hypothesis that some neurodegenerative events associated with ageing of the central nervous system (CNS) may be due to a lack of neurotrophic support to neurons is suggestive of a possible reparative pharmacological strategy intended to enhance the activity of endogenous neurotrophic agents. Here we report that treatment with acetyl-l-carnitine (ALCAR), a substance which has been shown to prevent some impairments of the aged CNS in experimental animals as well as in patients, is able to increase the levels and utilization of nerve growth factor (NGF) in the CNS of old rats. The stimulation of NGF levels in the CNS can be attained when ALCAR is given for long or short periods to senescent animals of various ages, thus indicating a direct effect of the substance on the NGF system which is independent of the actual degenerative stage of the neurons. Furthermore, long-term treatment with ALCAR completely prevents the loss of choline acetyltransferase (ChAT) activity in the CNS of aged rats, suggesting that ALCAR may rescue cholinergic pathways from age-associated degeneration due to lack of retrogradely transported NGF.

Original languageEnglish (US)
Pages (from-to)55-66
Number of pages12
JournalExperimental Gerontology
Volume29
Issue number1
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Acetylcarnitine
Choline O-Acetyltransferase
Carnitine
Neurology
Nerve Growth Factor
Rats
Central Nervous System
Neurons
Animals
Therapeutics
Cholinergic Agents
Aging of materials
Pharmacology

Keywords

  • acetyl-l-carnitine
  • aging
  • CNS
  • nerve growth factor
  • neurodegeneration

ASJC Scopus subject areas

  • Aging
  • Medicine(all)

Cite this

Acetyl-l-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats. / Taglialatela, Giulio; Navarra, D.; Cruciani, R.; Ramacci, M. T.; Alemà, G. S.; Angelucci, L.

In: Experimental Gerontology, Vol. 29, No. 1, 1994, p. 55-66.

Research output: Contribution to journalArticle

@article{738a2cc5a0054fc8a96c8cb3c0bece9d,
title = "Acetyl-l-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats",
abstract = "The hypothesis that some neurodegenerative events associated with ageing of the central nervous system (CNS) may be due to a lack of neurotrophic support to neurons is suggestive of a possible reparative pharmacological strategy intended to enhance the activity of endogenous neurotrophic agents. Here we report that treatment with acetyl-l-carnitine (ALCAR), a substance which has been shown to prevent some impairments of the aged CNS in experimental animals as well as in patients, is able to increase the levels and utilization of nerve growth factor (NGF) in the CNS of old rats. The stimulation of NGF levels in the CNS can be attained when ALCAR is given for long or short periods to senescent animals of various ages, thus indicating a direct effect of the substance on the NGF system which is independent of the actual degenerative stage of the neurons. Furthermore, long-term treatment with ALCAR completely prevents the loss of choline acetyltransferase (ChAT) activity in the CNS of aged rats, suggesting that ALCAR may rescue cholinergic pathways from age-associated degeneration due to lack of retrogradely transported NGF.",
keywords = "acetyl-l-carnitine, aging, CNS, nerve growth factor, neurodegeneration",
author = "Giulio Taglialatela and D. Navarra and R. Cruciani and Ramacci, {M. T.} and Alem{\`a}, {G. S.} and L. Angelucci",
year = "1994",
doi = "10.1016/0531-5565(94)90062-0",
language = "English (US)",
volume = "29",
pages = "55--66",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Acetyl-l-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats

AU - Taglialatela, Giulio

AU - Navarra, D.

AU - Cruciani, R.

AU - Ramacci, M. T.

AU - Alemà, G. S.

AU - Angelucci, L.

PY - 1994

Y1 - 1994

N2 - The hypothesis that some neurodegenerative events associated with ageing of the central nervous system (CNS) may be due to a lack of neurotrophic support to neurons is suggestive of a possible reparative pharmacological strategy intended to enhance the activity of endogenous neurotrophic agents. Here we report that treatment with acetyl-l-carnitine (ALCAR), a substance which has been shown to prevent some impairments of the aged CNS in experimental animals as well as in patients, is able to increase the levels and utilization of nerve growth factor (NGF) in the CNS of old rats. The stimulation of NGF levels in the CNS can be attained when ALCAR is given for long or short periods to senescent animals of various ages, thus indicating a direct effect of the substance on the NGF system which is independent of the actual degenerative stage of the neurons. Furthermore, long-term treatment with ALCAR completely prevents the loss of choline acetyltransferase (ChAT) activity in the CNS of aged rats, suggesting that ALCAR may rescue cholinergic pathways from age-associated degeneration due to lack of retrogradely transported NGF.

AB - The hypothesis that some neurodegenerative events associated with ageing of the central nervous system (CNS) may be due to a lack of neurotrophic support to neurons is suggestive of a possible reparative pharmacological strategy intended to enhance the activity of endogenous neurotrophic agents. Here we report that treatment with acetyl-l-carnitine (ALCAR), a substance which has been shown to prevent some impairments of the aged CNS in experimental animals as well as in patients, is able to increase the levels and utilization of nerve growth factor (NGF) in the CNS of old rats. The stimulation of NGF levels in the CNS can be attained when ALCAR is given for long or short periods to senescent animals of various ages, thus indicating a direct effect of the substance on the NGF system which is independent of the actual degenerative stage of the neurons. Furthermore, long-term treatment with ALCAR completely prevents the loss of choline acetyltransferase (ChAT) activity in the CNS of aged rats, suggesting that ALCAR may rescue cholinergic pathways from age-associated degeneration due to lack of retrogradely transported NGF.

KW - acetyl-l-carnitine

KW - aging

KW - CNS

KW - nerve growth factor

KW - neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=0028175075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028175075&partnerID=8YFLogxK

U2 - 10.1016/0531-5565(94)90062-0

DO - 10.1016/0531-5565(94)90062-0

M3 - Article

C2 - 8187841

AN - SCOPUS:0028175075

VL - 29

SP - 55

EP - 66

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

IS - 1

ER -